Company: PCAP
Filing Date: 2025-05-22
Form Type: 424B4
Source: 0001213900-25-046578
Chunk: 167

Company: ProCap Acquisition Corp
Filing Date: 2025-05-22
Form: 424B4
Chunk 167
---
. From September 2018 to May 2021, Ms. Haswell served as the Chief Legal and Administrative Officer of mobility company Lime, and was a founding member of Uber’s Legal Team, on which she served from January 2015 to November 2017. Ms. Haswell earned a degree in Political Science and Journalism from the University of Southern California and a law degree from the University of Southern California. We believe Ms. Haswell is well qualified to serve as a member of our board of directors due to her extensive strategic, operational and broad business experience. Ben Buchanan has served on our board of directors since the commencement of our listing on Nasdaq. Since January 2025, Mr.Buchanan has served as the Chief Executive Officer of All Current, a provider of electrical solutions. From September 2019 to July 2022, Mr.Buchanan served as Chief Financial Officer for LindFast Solutions Group, the leading master distributor of fasteners in North America. Mr.Buchanan then served as Executive Vice President and Chief Operating Officer of LindFast Solutions Group from July 2022 to October 2024. Prior to his time at LindFast Solutions Group, Mr.Buchanan served as the Chief Financial Officer of US Greenfiber, a cellulose insulation manufacturer, from July 2018 to August 2019. Additionally, Mr.Buchanan has served on the board of directors of Argus Monitoring Solutions since February 2022. Mr.Buchanan earned a degree in Economics from Samford University and an MBA from the University of Kentucky. We believe Mr.Buchanan is well qualified to serve as a member of our board of directors due to his extensive strategic, operational and broad business experience. Brent Saunders is serving as a Special Advisor to the Company. Mr. Saunders has served on the board of directors of TBHC since May 4, 2021 and currently serves as its chairman of the board. Mr. Saunders briefly served as Interim Chief Executive Officer of TBHC in January and February 2022, and as TBHC’s executive chairman of the board of directors for the fiscal year of 2022 until March 2023. Mr. Saunders has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Mr. Saunders served as Chairman, President and Chief Executive Officer of Allergan plc (“